SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-048232
Filing Date
2014-08-11
Accepted
2014-08-11 08:37:48
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v384689_10q.htm 10-Q 279613
2 EXHIBIT 31.1 v384689_ex31-1.htm EX-31.1 8433
3 EXHIBIT 31.2 v384689_ex31-2.htm EX-31.2 8374
4 EXHIBIT 32.1 v384689_ex32-1.htm EX-32.1 4332
5 EXHIBIT 32.2 v384689_ex32-2.htm EX-32.2 4085
  Complete submission text file 0001144204-14-048232.txt   4534117

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cndo-20140630.xsd EX-101.SCH 35639
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cndo-20140630_cal.xml EX-101.CAL 32547
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cndo-20140630_def.xml EX-101.DEF 272621
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cndo-20140630_lab.xml EX-101.LAB 341754
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cndo-20140630_pre.xml EX-101.PRE 309426
11 XBRL INSTANCE DOCUMENT cndo-20140630.xml EX-101.INS 692512
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 781-652-4500
CORONADO BIOSCIENCES INC (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 141029017
SIC: 2834 Pharmaceutical Preparations